J Blin

Summary

Country: Belgium

Publications

  1. ncbi request reprint Physostigmine results in an increased decrement in brain glucose consumption in Alzheimer's disease
    J Blin
    Laboratory of Positron Emission Tomography, Universityof Louvain, Louvain la Neuve, Belguim
    Psychopharmacology (Berl) 136:256-63. 1998

Detail Information

Publications1

  1. ncbi request reprint Physostigmine results in an increased decrement in brain glucose consumption in Alzheimer's disease
    J Blin
    Laboratory of Positron Emission Tomography, Universityof Louvain, Louvain la Neuve, Belguim
    Psychopharmacology (Berl) 136:256-63. 1998
    ..The observed weak response of clinical symptomatology to anticholinesterase agents does not appear to be due to the failure to enhance the activity of the cholinergic system in AD...